The collaboration came shortly after the company faced a serious setback, with the failure of a trial investigating an immunotherapy drug designed to treat lung cancer. One important attraction of using AI in drug discovery and development is its ability to generate data. This provides researchers with access to valuable data regarding the daily challenges experienced by patients.
The mobile app was developed by patients, neurologists, and disease advocates, and was built on the Apple ResearchKit platform, first used by GSK in a rheumatoid arthritis study. Together with the increasing innovation of wearable technologies, the use of mobile apps in clinical trials will allow manufacturers to collect clinical outcome data directly from patients, making trials more cost-effective and reflective of real-world situations. Linari NanoTech provides production systems used to create new drugs, cell culture scaffolds, resorbable prostheses, biomimetic coating, biosensors and wound dressing substrates.
EuroEspes Biotechnology Ebiotec develops novel bioproducts for the prevention and treatment of diseases such as brain disorders, cancers and metabolic syndromes. Nuvisan Pharma Service is a contract research organisation with decades of experience in pharmacological and pharmacokinetic studies, delivering a comprehensive range of solutions for clinical trials. Lunch and Learn Series to Begin on 7 October. Quick and Flexible Elemental Screening with Omnian. Clinical Trials Arena is using cookies We use them to give you the best experience. Continue Learn More X.
Advertise with us. Learn more Hover over the logos to learn more about the companies who made this project possible.
Essential CNS Drug Development
Preskorn, Sheldon. Kwentus, Joseph.
- New technologies are transforming CNS drug development?
- Essential CNS Drug Development - eBook - incatanpakym.tk.
- Livro - Essential Cns Drug Development - Kalali.
Stahl, Stephen M. Contents Preface-- 1. Preskorn-- 2.
- Frontiers in CNS Drug Discovery.
- The Tibetan Book of the Dead: Awakening Upon Dying;
- Heaven in the American Imagination.
- Stanford Libraries;
- Our Divine Soul within: science of the soul (Soul and Person Book 1).
Regulatory issues Gwen L. Zornberg-- 3. Pre-clinical development Alan J. Cross and Frank D. Yocca-- 4. Preskorn-- 5.
Essential CNS Drug Development [electronic resource]. in SearchWorks catalog
Feltner and Kenneth R. Evans-- 6. Mallinckrodt, William R.
- Weight Warriors.
- The Adventures of The Sizzling Six: Return of The Red-cockaded Clan (Eco Mysteries Book 5).
- Business Intelligence: The Savvy Managers Guide (The Morgan Kaufmann Series on Business Intelligence).
Prucka and Geert Molenberghs-- 8. Clinical trials management at company level Nuala Murphy-- 9. Clinical trials management at the site level Joseph Kwentus-- Dissemination of clinical trial information: multiple audiences, multiple formats Leslie Citrome-- The importance of treating cognition in schizophrenia and other severe mental illnesses: background, strategies, and findings to date Philip D. Harvey and Richard S.
Central Nervous System
Keefe-- The development of better treatments is crucial and is a major focus of pharmaceutical and biotechnology companies. This book explains the complicated process of CNS drug development in a way that is engaging for any interested professional or student. Chapters cover each stage of drug development, from pre-clinical research through all phases of clinical trials, to reporting to the regulatory authorities.
Other key issues covered include strategic considerations, regulatory constraints, dissemination of results and ethical considerations. The user-friendly format and style enable readers to find important information quickly and easily.